| 1 | MARK2, MARK4
|
| MARK2 and MARK4 Regulate Sertoli Cell BTB Dynamics Through Microtubule and Actin Cytoskeletons
|
| Tang EI, Cheng CY.
|
| Endocrinology. Oct 11;163(11):bqac130. doi: 10.1210/endocr/bqac130 2022
|
| 2 | MARK4
|
| Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) plays a role in cell cycle progression and cytoskeletal dynamics.
|
| Rovina D, Fontana L, Monti L, Novielli C, Panini N, Sirchia SM, Erba E, Magnani I, Larizza L.
|
| Eur J Cell Biol ur J Cell Biol. 2014 Jul 24. pii: S0171-9335(14)00091-0. doi: 10.1016/j.ejcb.2014.07.004. [Epub ahead of print]
2014
|
| 3 | MARK4
|
| Mark4 promotes adipogenesis and triggers apoptosis in 3T3-L1 adipocytes by activating JNK1 and inhibiting p38MAPK pathways.
|
| Feng M, Tian L, Gan L, Liu Z, Sun C.
|
| Biol Cell iol Cell. 2014 Jul 2. doi: 10.1111/boc.201400004. [Epub ahead of print]
2014
|
| 4 | MARK4
|
| Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease.
|
| Gu GJ, Lund H, Wu D, Blokzijl A, Classon C, von Euler G, Landegren U, Sunnemark D, Kamali-Moghaddam M.
|
| Neuromolecular Med 15(3):458-69. doi: 10.1007/s12017-013-8232-3. Epub 2013 May 12.
2013
|
| 5 | MARK4
|
| The microtubule affinity regulating kinase MARK4 promotes axoneme extension during early ciliogenesis.
|
| Kuhns S, Schmidt KN, Reymann J, Gilbert DF, Neuner A, Hub B, Carvalho R, Wiedemann P, Zentgraf H, Erfle H, Klingmüller U, Boutros M, Pereira G.
|
| J Cell Biol 200(4):505-22. doi: 10.1083/jcb.201206013. Epub 2013 Feb 11.
2013
|
| 6 | MARK4, MTOR
|
| Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) is a negative regulator of the mammalian target of rapamycin complex 1 (mTORC1).
|
| Li L, Guan KL.
|
| J Biol Chem 288(1):703-8. doi: 10.1074/jbc.C112.396903. Epub 2012 Nov 26.
2013
|
| 7 | MARK1, MARK2, MARK3, MARK4
|
| Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease.
|
| Gu GJ, Lund H, Wu D, Blokzijl A, Classon C, von Euler G, Landegren U, Sunnemark D, Kamali-Moghaddam M.
|
| Neuromolecular Med 15(3):458-69. doi: 10.1007/s12017-013-8232-3. Epub 2013 May 12.
2013
|
| 8 | MARK4
|
| A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Aβ on synapses and dendritic spines.
|
| Yu W, Polepalli J, Wagh D, Rajadas J, Malenka R, Lu B.
|
| Hum Mol Genet 21(6):1384-90. doi: 10.1093/hmg/ddr576. Epub 2011 Dec 8.
2012
|
| 9 | MARK4
|
| Differential signature of the centrosomal MARK4 isoforms in glioma.
|
| Magnani I, Novielli C, Fontana L, Tabano S, Rovina D, Moroni RF, Bauer D, Mazzoleni S, Colombo EA, Tedeschi G, Monti L, Porta G, Bosari S, Frassoni C, Galli R, Bello L, Larizza L.
|
| Anal Cell Pathol (Amst) 34(6):319-38. doi: 10.3233/ACP-2011-0031.
2011
|
| 10 | MARK4
|
| Multiple localization of endogenous MARK4L protein in human glioma.
|
| Magnani I, Novielli C, Bellini M, Roversi G, Bello L, Larizza L.
|
| Cell Oncol 31(5):357-70. doi: 10.3233/CLO-2009-0481.
2009
|
| 11 | MARK1, MARK2, MARK3, MARK4
|
| Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein.
|
| Timm T, Marx A, Panneerselvam S, Mandelkow E, Mandelkow EM.
|
| BMC Neurosci 9 Suppl 2:S9. doi: 10.1186/1471-2202-9-S2-S9. Review.
2008
|
| 12 | MARK1, MARK2, MARK3, MARK4
|
| Regulation of the polarity kinases PAR-1/MARK by 14-3-3 interaction and phosphorylation.
|
| Göransson O, Deak M, Wullschleger S, Morrice NA, Prescott AR, Alessi DR.
|
| J Cell Sci 119(Pt 19):4059-70. Epub 2006 Sep 12.PMID: 16968750 2006
|
| 13 | MARK4
|
| Identification of regulated genes during permanent focal cerebral ischaemia: characterization of the protein kinase 9b5/MARKL1/MARK4.
|
| Schneider A, Laage R, von Ahsen O, Fischer A, Rossner M, Scheek S, Grunewald S, Kuner R, Weber D, Kruger C, Klaussner B, Gotz B, Hiemisch H, Newrzella D, Martin-Villalba A, Bach A, Schwaninger M.
|
| J Neurochem 88(5):1114-26. 2004
|
| 14 | MARK4
|
| Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis.
|
| Kato T, Satoh S, Okabe H, Kitahara O, Ono K, Kihara C, Tanaka T, Tsunoda T, Yamaoka Y, Nakamura Y, Furukawa Y.
|
| Neoplasia 3(1):4-9. 2001
|